Clinical Trial Update: Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether adding tropisetron to risperidone improves cognitive and perceptual disturbances in schizophrenia; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• tropisetron (tropisetron)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Smoking Cessation, Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2014-09-08